About: Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
Creator	Thachil, Jecko Ageno, Walter Connors, Jean Hunt, Beverley Iba, Toshiaki Levi, Marcel Levy, Jerrold Marc Samama, Charles Spyropoulos, Alex Zucker, Barbara Douketis, James Giannis ¶ ¶, Dimitrios
source	Medline; PMC
abstract	The novel coronavirus disease of 2019 (COVID‐19) pandemic, as declared by the World Health Organization, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2). Cardiovascular disease and, in particular, venous thromboembolism (VTE) has emerged as an important consideration in the management of hospitalized patients with COVID‐19. The diagnosis of VTE using standardized objective testing is problematic in these patients, given the risk of infecting non‐COVID‐19 hospitalized patients and hospital personnel, coupled with the usual challenges of performing diagnostic testing in critically‐ill patients. Early reports suggest a high incidence of VTE in hospitalized COVID‐19 patients, particularly those with severe illness, that is similar to the high VTE rates observed in patients with other viral pneumonias, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS‐CoV).
has issue date	2020-05-27(xsd:dateTime)
bibo:doi	10.1111/jth.14929
bibo:pmid	32459046
has license	no-cc
sha1sum (hex)	5890d201f5b17b27887db5f69c08fc0061aceeeb
schema:url	https://doi.org/10.1111/jth.14929
resource representing a document's title	Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
has PubMed Central identifier	PMC7283841
has PubMed identifier	32459046
schema:publication	J Thromb Haemost
resource representing a document's body	covid:5890d201f5b17b27887db5f69c08fc0061aceeeb#body_text
is schema:about of	named entity 'Scientific' named entity 'Communication' named entity 'Committee' named entity 'Patients' named entity 'Venous Thromboembolism' named entity 'Standardization' named entity 'VTE' named entity 'acute phase reactants' named entity 'Middle East respiratory syndrome' named entity 'LMWH' named entity 'COVID' named entity 'VTE' named entity 'sepsis' named entity 'LMWH' named entity 'pneumonia' named entity 'LMWH' named entity 'COVID' named entity 'antiviral agents' named entity 'hospital discharge' named entity 'contraindicated' named entity 'healthcare workers' named entity 'healthcare worker' named entity '1, 2' named entity 'co-morbid' named entity 'warfarin' named entity 'COVID-19' named entity 'anticoagulation' named entity 'VTE' named entity 'thromboprophylaxis' named entity 'LMWH' named entity 'microthrombi' named entity 'morbid obesity' named entity 'pneumonia' named entity 'UFH' named entity 'venous thromboembolism' named entity 'thromboprophylaxis' named entity 'practice guidelines' named entity 'LMWH' named entity 'VTE' named entity 'edoxaban' named entity 'VTE' named entity 'COVID' named entity 'COVID' named entity 'UFH' named entity 'ARDS' named entity 'dalteparin' named entity 'SIC' named entity 'VTE' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'thromboprophylaxis' named entity 'VTE' named entity 'influenza H1N1' named entity 'Anticoagulation' named entity 'BMI' named entity 'pneumonia' named entity 'SARS' named entity 'thrice' named entity 'COVID-19' named entity 'fondaparinux' named entity 'low-molecular-weight heparin' named entity 'hypercoagulability' named entity 'Padua' named entity 'cytokine storm' named entity 'anticoagulants' named entity 'critically ill' named entity 'COVID' named entity 'prophylaxis' named entity 'VTE' named entity 'VTE' named entity 'American Heart Association'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software